LysoPC (20:4)
LysoPC (20:4) is a type of lysophosphatidylcholine. The level of LysoPC (20:4) is negatively correlated with cancer risk. LysoPC (20:4) may promote tumor progression through the lysophosphatidic acid (LPA) signaling pathway[1].
Product Specifications
CAS Number
60701-99-7
Product Name Alternative
1-Arachidonoyl-sn-glycero-3-phosphocholine
UNSPSC
12352211
Target
Endogenous Metabolite
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
C[N+](C)(C)CCOP(OC[C@H](O)COC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)([O-])=O
Molecular Formula
C28H50NO7P
Molecular Weight
543.67
References & Citations
[1]Kühn T, et al. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med. 2016 Jan 28;14:13.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY422232 100 µg
SH3PXD2B (NM_001017995) Human Over-expression Lysate
Sign In for Pricing
View Details